Decision Diagnostics (DECN)

Currency in USD
0.0001
0.0000(0.00%)
Closed·
DECN Scorecard
Full Analysis
Stock generally trades with low price volatility
Trading near 52-week High
Fair Value
Day's Range
0.00010.0001
52 wk Range
0.00010.0001
Key Statistics
Prev. Close
-
Open
0.0001
Day's Range
0.0001-0.0001
52 wk Range
0.0001-0.0001
Volume
-
Average Volume (3m)
150
1-Year Change
0%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DECN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Neutral
Moving Averages
Strong Buy

Decision Diagnostics Company Profile

Decision Diagnostics Corp. develops smart phone based electronic medical record (EMR) technologies. The company offers prescription and non-prescription diagnostics; home testing products for the chronically ill; fulfillment services to direct to patient diabetes programs; and cell phone centric e-health products and technologies development services. It manufactures and distributes GenUltimate! glucose test strips, a Class II medical device for at-home use for the measurement of glucose; PetSure! glucose test strip for the glucose testing of dogs and cats designed to work with the Zoetis AlphaTrak and AlphaTrak II glucometers, a legacy meter; GenUltimate! 4Pets Glucose system, a proprietary glucose measuring system, including GenUltimate! 4Pets test strip and Avantage meter, for the testing of dogs, cats, and horses; and GenUltimate! Sure and GenUltimate! Precis test strips. In addition, it engages in the acquisition and holding of intellectual property including patents and trademarks and specialty manufacturing equipment. Further, the company also provides MD@Hand, an inpatient/outpatient management suite; Practice Probe, a data mining utility used to extract information from the physician’s practice management system; and ResidenceWare, a residential management system that facilitates the relay of information from commercial and residential real estate management companies to occupying tenants using networking software systems and applications. Its EMR technologies are used by physicians at the point of care. The company was formerly known as InstaCare Corp. and changed its name to Decision Diagnostics Corp. in November 2011. Decision Diagnostics Corp. was founded in 2000 and is based in Westlake Village, California.

Compare DECN to Peers and Sector

Metrics to compare
DECN
Peers
Sector
Relationship
P/E Ratio
0.0x−1.9x−0.5x
PEG Ratio
0.00−0.010.00
Price/Book
0.0x1.5x2.6x
Price / LTM Sales
0.0x2.5x3.2x
Upside (Analyst Target)
0.0%39.1%45.7%
Fair Value Upside
Unlock9.5%8.6%Unlock

Earnings

Latest Release
Nov 27, 2024
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

DECN Income Statement

FAQ

What Stock Exchange Does Decision Diagnostics Trade On?

Decision Diagnostics is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Decision Diagnostics?

The stock symbol for Decision Diagnostics is "DECN."

What Is the Decision Diagnostics Market Cap?

As of today, Decision Diagnostics market cap is 38.05K.

What Is Decision Diagnostics's Earnings Per Share (TTM)?

The Decision Diagnostics EPS (TTM) is -0.02.

From a Technical Analysis Perspective, Is DECN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Decision Diagnostics Stock Split?

Decision Diagnostics has split 4 times.

How Many Employees Does Decision Diagnostics Have?

Decision Diagnostics has 8 employees.

What is the current trading status of Decision Diagnostics (DECN)?

As of 02 Aug 2025, Decision Diagnostics (DECN) is trading at a price of 0.00, with a previous close of 0.00. The stock has fluctuated within a day range of 0.00 to 0.00, while its 52-week range spans from 0.00 to 0.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.